Lifeng Qi
Affiliations: | University of Washington, Seattle, Seattle, WA |
Google:
"Lifeng Qi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhao J, Tu K, Liu Y, et al. (2017) Photo-controlled aptamers delivery by dual surface gold-magnetic nanoparticles for targeted cancer therapy. Materials Science & Engineering. C, Materials For Biological Applications. 80: 88-92 |
| Wang L, Wu W, Wang J, et al. (2016) Highly efficient Gab2 siRNA delivery to ovarian cancer cells mediated by chitosan-polyethyleneimine nanoparticles. Journal of Materials Chemistry. B. 4: 273-281 |
| Chen Y, Xu M, Guo Y, et al. (2016) Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle. Nanotechnology. 28: 025101 |
| Qi L, Liu J, Zhu H, et al. (2014) Inhibition of glioma proliferation and migration by magnetic nanoparticle mediated JAM-2 silencing. Journal of Materials Chemistry. B. 2: 7168-7175 |
| Qi L, Shao W, Shi D. (2013) JAM-2 siRNA intracellular delivery and real-time imaging by proton-sponge coated quantum dots. Journal of Materials Chemistry. B. 1: 654-660 |
| Qi L, Wu L, Zheng S, et al. (2012) Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Biomacromolecules. 13: 2723-30 |
| Qi L, Zheng S, Lin B. (2010) Recent patents on imaging nanoprobes for brain tumor diagnosis and therapy. Recent Patents On Biotechnology. 4: 130-5 |
| Qi L, Gao X. (2008) Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. Acs Nano. 2: 1403-10 |
| Yezhelyev MV, Qi L, O'Regan RM, et al. (2008) Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. Journal of the American Chemical Society. 130: 9006-12 |
| Qi L, Gao X. (2008) Emerging application of quantum dots for drug delivery and therapy. Expert Opinion On Drug Delivery. 5: 263-7 |